Kraig Biocraft Laboratories Inc (KBLB)

[DimesForShares]

Blue raises the question of plausibility, claiming those who are repeatedly critical should find it ‘easier’ to place their money on another company and therefore their complaints are not plausible.

One could, of course, turn the argument around. Posters who have championed a stock that has lost around 94% of its value during the last 4 years but have insisted that success will happen ‘soon’ over that same period of time appear to have little plausibility in their ebullient and entirely inaccurate predictions of success happening ‘soon.’

Wouldn’t it be easier for champions of KBLB to place their money on another company that has increased its value rather than plummeted?

Why do you feel the critical posts lack plausibility when the stock has been bleeding out since 2019? Those posts have a much better track record of accuracy than $8/share buyout predictions, wouldn’t you agree?

I suspect you may believe that the share price would go up if all of the criticism disappeared from iHub. Historically, share price declines occur because of bad news or an absence of good news from the company. There is no evidence I am aware of that demonstrates a relationship between critical posts and share price movement after considering the impact of company communications. If you want to look for villains in this situation, I recommend you focus your ire on Thomson, not some grouchy iHub members.